Healthcare AI Acquisition Corp.

Healthcare AI Acquisition Corp.

HAIAU
Healthcare AI Acquisition Corp.US flagNASDAQ Global Market
11.50
USD
+11.50
- -
63.75MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Net Income, GAAP
- -
13
4
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
Working Capital
1
- -
-1
-1
-1
LT Debt
- -
- -
- -
- -
- -
Total Equity
202
214
5
3
3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
6.15
3.94
1.2
9.56
Return on Common Equity (%)
- -
6.15
3.95
1.43
11.81

Capital Structure

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'24
Dec'24
Mar'25
Total Current Assets
- -
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
2
2
Payables & Accruals
- -
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-40.03%
Free Cash Flow
- -
- -
11.24%
Net Income, GAAP
- -
- -
-98.69%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Jiande Chen
Full Time Employees
2
Sector
Financial Services
Industry
Shell Companies
Address
190 Elgin Avenue George Town Cayman Islands 10177
IPO Date
Dec 10, 2021
Business
Healthcare AI Acquisition Corp. Healthcare AI Acquisition Corp. (HAIAU) operates as a blank check company, or special purpose acquisition company (SPAC), with no significant ongoing business operations; it focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting companies in the healthcare and pharmaceutical sectors, including e-Clinical solutions, healthcare information technology, and outsourced pharmaceutical services with high AI readiness and technological transformation potential. Incorporated in 2021 as a Cayman Islands exempted company and headquartered at 190 Elgin Avenue, George Town, Cayman Islands, the company is a subsidiary of Atticus Ale, LLC and maintains its principal executive offices in locations such as Dover, Delaware, or Albany, New York; it trades its units on Nasdaq under the ticker HAIAU, with separate Class A ordinary shares (HAIA) and warrants (HAIAW or HAIWF). Geographically, while the SPAC itself has no operations, it seeks targets with global potential, particularly in healthcare AI applications. In recent developments, Healthcare AI Acquisition Corp. entered into a definitive Business Combination Agreement on August 15, 2024, with Leading Group Limited, a licensed digital insurance broker and insurance channel specialist in China providing digital insurance brokerage, integrated marketing services, and tailored solutions to insurance carriers, individual policyholders, and corporate clients to enhance premium sales growth and customer acquisition; the transaction, valued at approximately $430 million for Leading Group with an additional $50 million private placement financing, contemplates a series of mergers where Leading Group shareholders will hold a majority of the combined company and appoint most directors, with completion originally targeted for Q4 2024 but repeatedly extended through shareholder approvals, including month-to-month deadlines to October 14, 2026, supported by monthly $0.10 per share deposits into trust and unsecured promissory notes to Leading Group for working capital. As of late 2025, the proposed merger remains pending shareholder and regulatory approvals, with the combined entity expected to list on Nasdaq and accelerate Leading Group's organic growth in China's insurance services market.

Company News

APIChatGPT
  • U.S. IPO Weekly Recap: Digital Banking Leads A 3 IPO Week